Hisamitsu Ide, Yuko Akehi, Shinichiro Fukuhara, Shin Ohira, Sumito Ogawa, Tomoya Kataoka, Hiroshi Kumagai, Ko Kobayashi, Akira Komiya, Kazuyoshi Shigehara, Takahiro Syuto, Jintetu Soh, Makito Tanabe, Hisanori Taniguchi, Koji Chiba, Kazuhito Matsushita, Yozo Mitsui, Takahiro Yoneyama, Tomoya Shirakawa, Yasuhisa Fujii, Hiroaki Kumano, Hajime Ueshiba, Toshiyasu Amano, Haruaki Sasaki, Seiji Maeda, Atsushi Mizokami, Kazuhiro Suzuki, Shigeo Horie
doi : 10.1111/iju.15160
Testosterone plays an important role in maintaining both physical and mental function. Age-related testosterone depletion contributes to the development of angina, arteriosclerosis, obesity, metabolic syndrome, dementia, frailty, and a range of other conditions.
Koki Maeda, Katsumi Shigemura, Masato Fujisawa
doi : 10.1111/iju.15149
Prostatitis is classified into four categories according to the National Institutes of Health Consensus Classification. The largest category, Category III chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS), has a wide range of symptoms and is difficult to diagnose because diagnosis is based on exclusion.
Paloma Sosa-Fajardo, Jesús M. Blanco-Suarez, Ã�lvaro Pineda-MunguÃa, Luz RubÃ-Olea, Paula Peleteiro-Higuero, Pablo Gajate, Juan Zafra-MartÃn, Shankar Siva, Alberto Bossi, Fernando López-Campos, Felipe Couñago
doi : 10.1111/iju.15156
At present, surgery is still the gold standard for the local treatment of renal cancer. Nonetheless, in several clinical scenarios, stereotactic body radiation therapy (SBRT) also known as stereotactic ablative body radiotherapy (SABR) is emerging as a highly effective ablative technique in fragile patients and those with significant comorbidities, as well as in cases where percutaneous therapy (cryoablation or radiofrequency) is not viable.
Yusuke Goto MD, PhD
doi : 10.1111/iju.15167
Tomohiko Hara
doi : 10.1111/iju.15152
This study aimed to assess the effect sizes, changes over time, and ethnic differences in placebo effects on urinary function among Japanese patients participating in clinical trials.
Takeya Kitta MD, PhD
doi : 10.1111/iju.15191
Shotaro Sakka, Shuya Kandori, Koji Kawai, Takahiro Kojima, Satoshi Nitta, Ichiro Chihara, Yoshiyuki Nagumo, Takashi Kawahara, Bryan J. Mathis, Megumi Ishihara, Nobuo Shinohara, Takeshi Kishida, Osamu Ukimura, Kazuo Nishimura, Yasuyuki Kobayashi, Hiroyuki Nishiyama
doi : 10.1111/iju.15155
Molecular analysis of tumor tissues has been extensively analyzed in germ cell tumors. However, genetic analysis of plasma circulating tumor DNA has been limited. Our objective was to analyze genetic alterations in circulating tumor DNA as well as its impact on prognosis in patients with chemo-refractory germ cell tumors.
Takeshi Yuasa MD, PhD
doi : 10.1111/iju.15166
Katsuhisa Tsuruta, Tsuyoshi Majima, Toshinori Nishikimi, Ayano Kashima, Yuya Soeda, Satoshi Inoue, Tomoyasu Sano, Motohiro Maeda, Akiyuki Yamamoto, Ikuo Kobayashi, Keishi Kajikawa, Yoshihisa Matsukawa, Masahi Kato, Toyonori Tsuzuki, Naoto Sassa
doi : 10.1111/iju.15157
Zhen Wei Choo MBBS, MRCS, FAMS (Urology), Jeffrey J. Leow MBBS, MPH, MRCS, FAMS (Urology), Elise Vong MBBS, MRCP, Puey Ling Chia MBBS, MRCS, MMed, FRACP, PhD
doi : 10.1111/iju.15194
Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama, Nobutaka Nishimura, Kenta Onishi, Kouta Iida, Masaya Yonemori, Hideki Enokida, Masayuki Nakagawa, Hiroaki Matsumoto, Hideyasu Matsuyama, Yuto Matsushita, Hideaki Miyake, Tomomi Fujii, Keiji Shimada, Satoshi Baba, Mitsuru Kinjyo, Tatsuro Shimokama, Koji Okumura, Kiyohide Fujimoto, Nishinihon Uro-oncology Extensive Collaboration group
doi : 10.1111/iju.15162
To validate the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer and provide a more accurate stratification model for a heterogeneous intermediate-risk group.
Kazuhiro Matsumoto MD, PhD
doi : 10.1111/iju.15177
Masayoshi Okumi, Kazuya Omoto, Tomokazu Shimizu, Hiroki Shirakawa, Kohei Unagami, Takumi Lee, Hideki Ishida, Kazunari Tanabe, Toshio Takagi
doi : 10.1111/iju.15163
To evaluate the 10-year efficacy and safety of a prolonged-release tacrolimus-based combination immunosuppressive regimen on longer-term outcomes in living donor kidney transplantation.
Kosuke Hamada MD, Yoshinobu Komai MD, PhD, Ryo Fujiwara MD, PhD, Noboru Numao MD, PhD, Shinya Yamamoto MD, PhD, Junji Yonese MD, PhD
doi : 10.1111/iju.15153
Go Anan, Hiromichi Iwamura, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Makoto Sato
doi : 10.1111/iju.15159
Zhenbang Liu MBBS, MRCS, FAMS (Urology), Jeffrey J. Leow MBBS, MPH, MRCS, FAMS (Urology), Daniel Z. P. Yong MD, MRCS, FAMS (Urology), MBiot, MEng
doi : 10.1111/iju.15200
Do you want to add Medilib to your home screen?